Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/13765| Title: | Patient centricity : the patient ambassador program at Grunenthal |
| Authors: | Grunenthal Group |
| Keywords: | Patient care Pharmaceutical industry -- Germany |
| Issue Date: | 2014 |
| Publisher: | Medical Portals Ltd. |
| Citation: | Grünenthal Group. (2014). Patient centricity : the patient ambassador program at Grunenthal. The Synapse, 13(2), 19 |
| Abstract: | The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain treatment, its objective is to become the most patient-centric company in the field of pain and thus to be a leader in therapy innovation. Grünenthal is one of the last remaining five research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/13765 |
| Appears in Collections: | The Synapse, Volume 13, Issue 2 The Synapse, Volume 13, Issue 2 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Patient centricity.pdf | 367.9 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.